Senior Scientist
Roche Pharma Research and Early Development, Switzerland
Gianluigi Lichinchi received his PhD at the Sanford Burnham Institute in La Jolla (California) working on RNA modifications and epitranscriptomics in 2017. He then joined the Therapeutic Modalities department at Roche. Gianluigi is working on the design and screening of nucleic acid-based medicines ranging from antisense oligonucleotides to gene and RNA editing molecules.
Wednesday, May 24, 2023
14:30 – 16:00 CET
Design and screening of therapeutic antisense oligonucleotides
Wednesday, May 24, 2023
14:30 – 15:00 CET